Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer

This study is currently recruiting participants.
Verified July 2013 by University of California, San Francisco
Sponsor:
Collaborators:
Susan G. Komen Breast Cancer Foundation
Plexxikon
Eisai Inc.
Information provided by (Responsible Party):
Hope Rugo, MD, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01596751
First received: May 7, 2012
Last updated: July 12, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2016
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)